Hone Health Review

Hone Health is a telehealth hormone platform that owns the full loop: an at-home finger-prick test, a clinician review of the result, a prescription where one is warranted, and medication shipped to the door. That vertical integration is the product. Most competitors hand off at least one of those steps to a lab, a pharmacy, or a separate provider, and each handoff adds days and friction.

The marketing frames Hone as a longevity platform. The panel does not support that framing. Hone measures hormones and the safety markers that hormone therapy requires, and it measures them well. It does not measure ApoB, Lp(a), fasting insulin, or the wider inflammation and nutrient set that a general longevity program covers. Read Hone as a hormone program with a very short path from question to prescription, and the pricing and the panel both make sense.

Scorecard

What you get for the money

The entry purchase is a test, not a membership commitment. Roughly $45 buys a finger-prick collection kit, prepaid return shipping, lab processing, and a clinician read of the result. If the clinician determines that TRT is appropriate and you accept, the relationship converts to an ongoing monthly protocol.

Here is what falls on each side of the line.

• Bundled at entry: the at-home collection kit, return shipping, lab processing, the results report, and the clinician's review of whether you are a candidate.
• Bundled in the monthly protocol: the prescribed medication, injection supplies where the protocol uses them, shipping, and ongoing clinician oversight including dose adjustments.
• Bundled in a limited way: messaging access to the care team between visits. This is asynchronous. Answers arrive in hours to a day, not in a scheduled conversation.
• Not bundled — ancillary medications. Aromatase inhibitors, hCG, or enclomiphene added to a protocol are priced on top of the base monthly figure.
• Not bundled — follow-up lab work. Titration and maintenance labs are ordered as needed and billed separately. Cost varies by market and by whether you use insurance.
• Not bundled — anything outside hormones. Lipid management, metabolic work, and nutrient repletion are not part of the program. If your ApoB is high, Hone is not where that gets addressed.

What it costs

Hone's headline number is the $45 test, which is a screening price rather than a program price. The number that matters is the monthly protocol cost once treatment starts, because TRT is not a course of treatment with an end date. Someone who starts at 35 and responds well is looking at a recurring monthly line item indefinitely.

The spread between $150 and $220+ per month is mostly protocol composition. Testosterone cypionate alone sits at the low end. Adding hCG to preserve testicular function, or an aromatase inhibitor to manage estradiol conversion, moves the figure up. Ask what the protocol will look like at month six, not at month one — the starting protocol is often the cheapest one you will be on.

Signing up and the first visit

The kit ships after checkout and arrives in a few days. Collection is a lancet finger-prick onto a card or into a small collection device, done at home, and it takes about ten minutes including the wait for the sample to fill. Testosterone follows a diurnal curve that peaks in the morning, so the instructions specify an early collection. Ignoring that instruction is the most common reason a result comes back artificially low.

You mail the sample back in the prepaid envelope. Results typically post in 5–7 days from receipt. The report gives each marker with a reference range and a flag for out-of-range values, alongside a clinician's written interpretation of whether the pattern is consistent with hypogonadism. Total elapsed time from order to clinical answer is usually two to three weeks.

A clinician visit follows for anyone proceeding toward a prescription. This is a telehealth appointment, and in most markets it must be synchronous because testosterone is a Schedule III controlled substance. The visit covers symptom history, contraindications, and fertility plans. If a prescription is written, medication ships from a partner pharmacy, generally within a week. Onboarding from first order to first dose commonly runs three to five weeks.

What the panel covers

Hone's panel is built around one clinical question — is this person a candidate for hormone therapy, and is it safe to start — rather than around general health surveillance. The marker groups are:

• Androgens. Total testosterone and free testosterone. Free testosterone is the more useful of the two in men with abnormal binding protein levels.
• Binding and conversion. SHBG and estradiol. SHBG determines how much of your total testosterone is bioavailable; estradiol tracks aromatase conversion, which rises with body fat and with dose.
• Pituitary signalling. LH and FSH, which separate a testicular cause from a pituitary or hypothalamic one. This distinction changes the treatment entirely and is the reason a bare testosterone number is not enough to act on.
• Safety markers for therapy. Hematocrit and hemoglobin via CBC, because exogenous testosterone raises red cell mass, and PSA, because therapy is not started without a prostate baseline.
• Metabolic and thyroid basics. A limited set, sufficient to catch an obvious confounder such as untreated hypothyroidism.

A worked example of why the pituitary markers matter: a man with total testosterone at 240 ng/dL and high LH has a testicular problem, and replacement is a reasonable answer. The same testosterone with low LH points upstream, and the correct next step is a prolactin check and often imaging, not a prescription. Programs that report testosterone without LH cannot make that distinction.

Strengths

• The at-home finger-prick removes the single largest drop-off point in hormone care — booking and attending a lab draw. No appointment, no fasting logistics, no travel.
• One vendor holds the test, the clinical decision, the prescription, and the pharmacy relationship. Nothing is lost in a handoff, and there is one place to call when something goes wrong.
• Monthly maintenance cost is below what in-person hormone clinics typically charge for the same protocol, and the difference compounds over the years that TRT is actually taken.
• The panel includes LH, FSH, and PSA rather than testosterone alone, so the clinician can distinguish primary from secondary hypogonadism and has a prostate baseline before starting.
• Scale brings operational reliability. Refills, shipping, and dose changes run on established processes rather than on a single provider's availability.
• Asynchronous messaging between visits means a side effect reported on a Tuesday gets an answer without waiting for the next scheduled appointment.

Trade-offs

• Panel breadth is narrow. ApoB, Lp(a), fasting insulin, hs-CRP, and the nutrient panel are absent, so cardiovascular and metabolic risk go unmeasured while you are on therapy.
• Follow-up lab costs are not in the headline price and vary by market, which makes the true annual figure harder to forecast than a flat-fee program's.
• Telehealth-first care limits the physical exam. A testicular exam, a blood pressure reading, and a prostate exam are not part of a video visit.
• The business model points toward treatment. A program that earns revenue from a monthly protocol has a structural reason to find candidates, which is an argument for a second opinion on a borderline result.
• Fertility preservation is not the default pathway. Standard TRT suppresses LH and FSH and impairs sperm production, and anyone planning to conceive needs an explicit conversation about enclomiphene or hCG before starting. Our guide to TRT and fertility covers how fast that suppression happens, how reversible it is, and what a restart involves.
• Support is asynchronous and text-based. Someone who wants an unhurried scheduled conversation with the same clinician each time will find the format thin.

How it compares

The four programs below are the closest comparison set: all are telehealth-first, all treat hormones, and all sell a recurring relationship rather than a one-off test. They are listed alphabetically, and the same six criteria are applied to each row.

The separations are real. Hone is the cheapest way to find out whether you are a candidate, because the entry test is $45 rather than a program fee. Lifeforce carries the widest routine panel of the four and bundles the clinician consult into the monthly figure. Marek Health goes deepest on labs and retests every 8–12 weeks during titration, which is why its realistic year-one range runs to $6,000+. Maximus is the one of the four built around an enclomiphene protocol, which matters specifically for men who want to raise testosterone without suppressing fertility.

Who should buy it — and who should not

Buy it if:

• You have symptoms consistent with low testosterone and want a cheap, fast, low-commitment way to test the hypothesis.
• You are already on TRT elsewhere, stable, and want to lower the recurring cost of maintenance.
• Getting to a lab is the thing that has stopped you before, and an at-home kit removes that barrier.
• You want one vendor holding the test, the prescription, and the pharmacy rather than coordinating three.
• Your general health markers are already being tracked somewhere else, so a hormone-only panel is not a gap.

Look elsewhere if:

• You want a broad annual biomarker picture — buy Function Health or Superpower at $499/yr for 100+ markers instead.
• You are trying to conceive in the next few years — look at Maximus for its enclomiphene protocol, which preserves LH and FSH.
• You want frequent, deep lab work during titration — Marek Health retests every 8–12 weeks and lets you build the panel.
• You want the clinician consult and the labs bundled into one monthly number — Lifeforce includes the nurse-practitioner review in its ~$129/mo.
• Your hormone question sits alongside metabolic, lipid, and inflammation questions — compare the doctor-led options that address all of them under one clinician.

One named exception worth flagging: if your hematocrit is already at or above 52%, adding exogenous testosterone raises it further and a telehealth-only program is a poor place to manage that. The same caution applies if PSA is elevated at baseline. Both are cases for in-person care before a prescription, whatever platform writes it.

Retesting and what year two costs

Once a protocol starts, the standard cadence is a check at 6–12 weeks to confirm the dose landed where intended, then maintenance labs every six to twelve months. Those checks exist because testosterone therapy has predictable, dose-driven side effects that are manageable when caught early, and our guide to TRT side effects and risks covers each of them alongside the contraindications that belong in the conversation before a first dose. The 6–12 week check is not optional. It is where hematocrit creep and estradiol over-conversion appear, and both are dose-driven and easily corrected if caught early.

Year two costs less than year one only because the $45 entry test does not repeat. Twelve months of a mid-range protocol lands at roughly $1,800–$2,650, plus lab work priced by your market. If the protocol has grown to include hCG or an aromatase inhibitor, expect the upper half of that range. The renewal does not include a broader panel, a physical exam, or anything outside hormone care — year two buys the same thing year one bought.

Budget realistically before starting. TRT taken correctly is a decade-scale commitment, and stopping after a year leaves you with suppressed natural production and a recovery period. The right comparison is not $45 against a competitor's entry fee. It is ten years of monthly protocol cost against ten years of an alternative.

Related

• All doctor-led options compared
• Lifeforce review
• Marek Health cost
• Maximus review
• Function Health alternatives
• Hone Health alternatives — six TRT options compared
• Is Hone Health worth it?
• Best TRT clinics
• SHBG — what it does and why it changes your free testosterone